scholarly journals Induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient carrying a PKD1 Q533X mutation

2017 ◽  
Vol 25 ◽  
pp. 83-87 ◽  
Author(s):  
Jia-Jung Lee ◽  
Ming-Ching Ho ◽  
Ching-Ying Huang ◽  
Cheng-Hao Wen ◽  
Yu-Che Cheng ◽  
...  
Keyword(s):  
Stem Cells ◽  
Kidney Disease ◽  
Induced Pluripotent Stem Cells ◽  
Polycystic Kidney Disease ◽  
Pluripotent Stem Cells ◽  
Autosomal Dominant ◽  
Disease Patient ◽  
Polycystic Kidney ◽  
Autosomal Dominant Polycystic Kidney ◽  
Induced Pluripotent

scholarly journals Cystic renal‐epithelial derived induced pluripotent stem cells from polycystic kidney disease patients

2020 ◽  
Vol 9 (4) ◽  
pp. 478-490 ◽  
Author(s):  
Annegien T. Kenter ◽  
Eveline Rentmeester ◽  
Job Riet ◽  
Ruben Boers ◽  
Joachim Boers ◽  
...  
Keyword(s):  
Stem Cells ◽  
Kidney Disease ◽  
Induced Pluripotent Stem Cells ◽  
Polycystic Kidney Disease ◽  
Pluripotent Stem Cells ◽  
Polycystic Kidney ◽  
Induced Pluripotent

scholarly journals Reduced Ciliary Polycystin-2 in Induced Pluripotent Stem Cells from Polycystic Kidney Disease Patients with PKD1 Mutations

2013 ◽  
Vol 24 (10) ◽  
pp. 1571-1586 ◽  
Author(s):  
Benjamin S. Freedman ◽  
Albert Q. Lam ◽  
Jamie L. Sundsbak ◽  
Rossella Iatrino ◽  
Xuefeng Su ◽  
...  
Keyword(s):  
Stem Cells ◽  
Kidney Disease ◽  
Induced Pluripotent Stem Cells ◽  
Polycystic Kidney Disease ◽  
Pluripotent Stem Cells ◽  
Polycystic Kidney ◽  
Induced Pluripotent

Peritoneal Dialysis for Patients with Autosomal Dominant Polycystic Kidney Disease

2017 ◽  
Vol 37 (4) ◽  
pp. 384-388 ◽  
Author(s):  
Sana Khan ◽  
Anna Giuliani ◽  
Carlo Crepaldi ◽  
Claudio Ronco ◽  
Mitchell H. Rosner
Keyword(s):  
Peritoneal Dialysis ◽  
Kidney Disease ◽  
Polycystic Kidney Disease ◽  
Autosomal Dominant ◽  
Disease Patient ◽  
Cystic Kidney ◽  
Polycystic Kidney ◽  
Autosomal Dominant Polycystic Kidney ◽  
Stage Renal Disease ◽  
End Stage

End-stage renal disease secondary to autosomal dominant poly-cystic kidney (ADPKD) is a common issue worldwide. Peritoneal dialysis (PD) is a reasonable option for renal replacement therapy for these patients and should not be withheld due to concerns that the patient may not tolerate the fluid volumes in the peritoneal cavity. This review covers the existing data on the outcomes and complications associated with the use of PD in the polycystic kidney disease patient. In general, PD is well tolerated and outcomes in ADPKD patients are equivalent to or better than other patient groups.

Sign in / Sign up

Export Citation Format

Share Document